Is BG a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Bunge Global SA (BG) rests on Viterra merger scale and synergies: The completed Viterra combination roughly doubles Bunge's trailing revenue base toward $70 billion and adds a leading grain-trading and origination network to Bunge's oilseed-processing strength. Revenue (TTM) is ~$70 billion. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Whether BG is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Bunge Global SA is a leading global agribusiness and food company that sources, stores, processes, transports, and sells agricultural commodities and food ingredients. It sits among the "ABCD" grain traders (ADM, Bunge, Cargill, Louis Dreyfus) and reports across three segments: Agribusiness (high-volume, low-margin oilseed processing and grain merchandising), Refined and Specialty Oils, and Milling. In July 2025 Bunge closed its roughly $8 billion merger with Glencore-backed Viterra, combining the top oilseed processor with a leading grain trader to form a group valued near $25 billion, and it sold its North American corn milling business the same month. The investment picture is one of scale plus cyclicality. Trailing revenue has jumped to roughly $70 billion as Viterra consolidates, but profitability is driven by the crush spread (the gap between soybean meal and oil prices and the cost of raw soybeans), which swings with harvests, biofuel demand, and trade policy. After a down year in 2024 and softer 2025, analysts model an earnings recovery in 2026 and 2027 as Viterra synergies and a broader footprint kick in, but the payoff depends on integration execution and a commodity backdrop Bunge does not control.
What's the case for buying BG?
1. Viterra merger scale and synergies
The completed Viterra combination roughly doubles Bunge's trailing revenue base toward $70 billion and adds a leading grain-trading and origination network to Bunge's oilseed-processing strength. Management frames the deal as a way to smooth commodity volatility through a more diversified and geographically balanced footprint. Realizing the targeted cost and volume synergies is the central multi-year driver of the earnings story.
2. Crush margins and biofuel demand
Core Agribusiness profitability tracks the crush spread, which is sensitive to soybean oil demand from renewable diesel and biofuel policy alongside global protein-meal consumption. Firm biofuel feedstock demand can lift oil values and widen crush economics. A sustained 10% move in average crush margins can swing annual EPS by roughly 8 to 12%, making this the single biggest earnings lever.
3. Portfolio reshaping and capital returns
Bunge has been pruning and reshaping, including selling its North American corn milling business in mid-2025, to focus capital on higher-return processing and value-added oils. The company pays a dividend yielding around 3% with a payout ratio near the mid-50s percent, leaving room for reinvestment in growth projects across its global plant network.
4. Earnings recovery expectations into 2026 and 2027
After adjusted EPS stepped down to roughly $7.57 in 2025 from higher prior-year levels, consensus models a rebound toward the mid-$9 range in 2026 and higher in 2027, largely on Viterra contribution and normalizing margins. That recovery is the crux of the forward valuation, which trades at a lower multiple on next year's expected earnings than on trailing results.
What are the risks to BG?
Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Expanded soybean and corn production in Brazil and Argentina intensifies competition and can pressure US export economics and margins. Integrating Viterra is a large, multi-year undertaking with execution, cultural, and cost risk, and the added debt and scale raise the stakes if the cycle turns. Biofuel and renewable-diesel policy shifts, tariffs, currency swings, and weather all add volatility to results. Because much of the bull case rests on a forecast earnings recovery, a shortfall against those estimates could weigh on the stock even after its strong run.
How is BG valued? (as of JULY 2026)
Snapshot for BG as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$70 billion
- Net income (TTM): ~$0.8 billion
- Market cap: ~$24 billion
- Adjusted EPS (FY2025): ~$7.57
- P/E (trailing / forward): ~25x / ~15x
- Dividend yield: ~3%
Trailing revenue jumped toward $70 billion as the Viterra merger consolidates, while net income of roughly $0.8 billion reflects a softer commodity-margin year. The gap between the trailing P/E near 25x and a forward P/E near 15x captures the market's expectation of an earnings recovery in 2026 as Viterra contributes and crush margins normalize. Figures are approximate and move with the underlying commodity cycle.
How do you decide if BG is a buy?
Rather than asking whether BG is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold BG indirectly through an index or sector ETF before adding more.
For the full picture, see the BG stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about BG against your real portfolio and see your actual exposure before deciding.
The bottom line on BG
The bottom line: Bunge Global SA's story right now is Viterra merger scale and synergies, with revenue (ttm) at ~$70 billion. If you believe that narrative continues, the call is about sizing BG sensibly and checking overlap with what you own; if you doubt it (the risk: bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around BG with Walnut
Use Bunge Global SA as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is BG a good stock to buy right now?
+
The case for Bunge Global SA right now is Viterra merger scale and synergies, with revenue (ttm) at ~$70 billion. If you believe that thesis holds, BG is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Bunge Global SA do?
+
Bunge Global SA is a leading global agribusiness and food company that sources, stores, processes, transports, and sells agricultural commodities and food ingredients.
What are the main risks of BG?
+
Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Expanded soybean and corn production in Brazil and Argentina intensifies competition and can pressure US export economics and margins. Integrating Viterra is a large, multi-year undertaking with execution, cultural, and cost risk, and the added debt and scale raise the stakes if the cycle turns. Biofuel and renewable-diesel policy shifts, tariffs, currency swings, and weather all add volatility to results. Because much of the bull case rests on a forecast earnings recovery, a shortfall against those estimates could weigh on the stock even after its strong run.
What does Bunge Global (BG) do?
+
Bunge is a global agribusiness that sources, stores, processes, transports, and sells agricultural commodities and food ingredients. It is one of the world's largest oilseed processors and grain traders, operating across Agribusiness, Refined and Specialty Oils, and Milling segments.
What happened with the Bunge-Viterra merger?
+
Bunge completed its roughly $8 billion merger with Glencore-backed Viterra in July 2025, combining a top oilseed processor with a leading grain trader to form a group valued near $25 billion. The deal is meant to broaden Bunge's footprint and reduce reliance on any single commodity cycle.
Is BG a good investment?
+
That depends on your goals, time horizon, and risk tolerance, and Walnut is not an investment adviser. BG is a cyclical commodity business whose earnings swing with crush margins and trade flows, so it behaves very differently from a steady grower. Consider how that volatility fits your own portfolio and do your own research.
Does Bunge pay a dividend?
+
Yes. BG pays a quarterly dividend yielding roughly 3%, with a per-share payout that has grown over recent years and a payout ratio in the mid-50s percent range. The dividend is one way the company returns cash while it reinvests in growth projects.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell BG; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.